A Novel FGFR3 Splice Variant Preferentially Expressed in African American Prostate Cancer Drives Aggressive Phenotypes and Docetaxel Resistance

Alternative splicing (AS) has been shown to participate in prostate cancer (PCa) development and progression; however, a link between AS and PCa health disparities has been largely unexplored. Here we report on the cloning of a novel splice variant of FGFR3 that is preferentially expressed in Africa...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Cancer Res
Autors principals: Olender, Jacqueline, Wang, Bi-Dar, Ching, Travers, Garmire, Lana X., Garofano, Kaitlin, Ji, Youngmi, Knox, Tessa, Latham, Patricia, Nguyen, Kenneth, Rhim, Johng, Lee, Norman H.
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6886680/
https://ncbi.nlm.nih.gov/pubmed/31266816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-19-0415
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars